Friday, 31 December 2010

Vasostenoon




Vasostenoon may be available in the countries listed below.


Ingredient matches for Vasostenoon



Alprostadil

Alprostadil is reported as an ingredient of Vasostenoon in the following countries:


  • Estonia

  • Latvia

International Drug Name Search

Monday, 27 December 2010

Oxytrol System


Pronunciation: OX-i-BUE-ti-nin
Generic Name: Oxybutynin
Brand Name: Oxytrol


Oxytrol System is used for:

Relieving symptoms of bladder problems (urinary urgency, frequency, or leakage; loss of bladder control; and painful urination) in certain patients. It may also be used for other conditions as determined by your doctor.


Oxytrol System is an anticholinergic. It works by relaxing muscles in the bladder.


Do NOT use Oxytrol System if:


  • you are allergic to any ingredient in Oxytrol System

  • you have bladder blockage or are unable to urinate

  • you have certain stomach or bowel problems (eg, blockage, decreased muscle movement)

  • you have uncontrolled narrow-angle glaucoma

  • you are taking a solid oral potassium product (eg, tablet)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Oxytrol System:


Some medical conditions may interact with Oxytrol System. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have trouble urinating or have very poor health

  • if you have a history of heart problems (eg, heart failure, fast or irregular heartbeat), high blood pressure, nervous system problems, liver or kidney problems, myasthenia gravis, an enlarged prostate, an overactive thyroid, esophagus problems (eg, reflux disease, inflammation, narrowing), stomach or bowel problems (eg, colitis, inflammation, constipation), or a hiatal hernia

  • if you have a history of glaucoma or increased pressure in the eyes, or if you are at risk of glaucoma (eg, family history of glaucoma)

Some MEDICINES MAY INTERACT with Oxytrol System. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Bisphosphonates (eg, alendronate) because the risk of irritation of the esophagus may be increased

  • Other anticholinergic medicines (eg, scopolamine), azole antifungals (eg, ketoconazole), or macrolide antibiotics (eg, erythromycin) because they may increase the risk of Oxytrol System's side effects

  • Solid oral potassium products (eg, tablets) because the risk of stomach or bowel irritation may be increased by Oxytrol System

  • Phenothiazines (eg, chlorpromazine) because their effectiveness may be decreased by Oxytrol System and they may increase the risk of Oxytrol System's side effects

This may not be a complete list of all interactions that may occur. Ask your health care provider if Oxytrol System may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Oxytrol System:


Use Oxytrol System as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • An extra patient leaflet is available with Oxytrol System. Talk to your pharmacist if you have questions about this information.

  • Apply the patch to a clean, dry, smooth area of your skin on your stomach, hips, or buttocks. Apply it to an area under clothing to protect it from sunlight. Avoid applying it to your waistline because clothing may rub against the patch.

  • Do NOT apply the patch to oily, damaged, or irritated skin. Avoid using oils, lotions, or powders near the application site because the patch may not stick to your skin.

  • To use Oxytrol System, open the pouch and remove the patch. Apply it right away. Carefully remove the first protective liner and place the patch firmly onto your skin. Do not touch the adhesive side of the patch. Bend the patch in half and gently roll the remaining part onto your skin. The second protective liner should come off of the patch. Gently apply firm pressure over the patch to be sure it stays in place.

  • When it is time to apply a new patch, remove the old patch carefully. Fold the patch in half with the sticky sides together. Discard the patch out of the reach of children and pets because it may still contain medicine.

  • Use a different skin site each time you apply a new patch. Do not reuse the same site within 7 days.

  • Use Oxytrol System on a regular schedule to get the most benefit from it. Using Oxytrol System at the same time each day will help you remember to use it.

  • Continue to use Oxytrol System even if you feel well. Do not miss any doses.

  • If the patch comes off, press it back in place and continue to follow your regular application schedule. If it does not stay on, throw it away and put a new patch on in a different area. Continue to follow your regular application schedule.

  • If you forget to change the patch on the correct day, remove the old patch and apply a new patch to a different application site as soon as you remember. Continue to follow your regular application schedule. Do not use 2 patches at once.

Ask your health care provider any questions you may have about how to use Oxytrol System.



Important safety information:


  • Oxytrol System may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Oxytrol System with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Check with your doctor before you drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Oxytrol System; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Oxytrol System may cause decreased sweating. Do not become overheated in hot weather or while you are being active; heatstroke may occur. Contact your doctor if you have been exposed to high temperatures and you develop fever; flushing; hot, dry skin; severe or persistent headache; dizziness; sudden fatigue; fast heartbeat; seizures; or fainting.

  • Oxytrol System may cause dry mouth. To help relieve dry mouth, suck on sugarless hard candy or ice chips, chew sugarless gum, drink water, or use a saliva substitute. Ask your doctor or pharmacist if you have any questions.

  • A serious side effect called angioedema has been reported with the use of oral dosage forms of Oxytrol System (eg, tablets). Contact your doctor at once if you develop swelling of the hands, face, lips, eyes, throat, or tongue; difficulty swallowing or breathing; or hoarseness.

  • Using Oxytrol System while bathing, swimming, showering, or exercising will not change the way it works. However, avoid rubbing the patch area during these activities.

  • Always remove the patch carefully and slowly to avoid damage to your skin. If there is adhesive left on your skin, gently wash the area with warm, soapy water. You may also use baby oil or a medical adhesive removal pad if needed. Do not use alcohol or nail polish remover because these may irritate the skin.

  • After removing the patch, there may be minor redness of your skin. It should disappear after several hours. Tell your doctor if the irritation or redness becomes worse or if it does not go away.

  • Use Oxytrol System with caution in the ELDERLY; they may be more sensitive to its effects.

  • Oxytrol System should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: It is not known if Oxytrol System can cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Oxytrol System while you are pregnant. It is not known if Oxytrol System is found in breast milk. If you are or will be breast-feeding while you use Oxytrol System, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Oxytrol System:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Blurred vision; constipation; diarrhea; dizziness; drowsiness; dry eyes, nose, skin, or mouth; headache; indigestion; nausea; minor redness, itching, or irritation at patch application site; stomach pain.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty swallowing or breathing; tightness in the chest; swelling of the mouth, face, lips, throat, or tongue; unusual hoarseness); confusion; difficult or painful urination; fast or irregular heartbeat; fever; hallucinations; mental or mood changes (eg, agitation); pain, burning, blistering, or oozing at the application site; seizures; swelling of the hands, ankles, or feet; vision problems.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Oxytrol side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include coma; delirium; fever; flushing; hallucinations; inability to urinate; irregular heartbeat; paralysis; seizures; severe or persistent dizziness or headache; tremor; trouble breathing; vomiting.


Proper storage of Oxytrol System:

Store Oxytrol System at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store in original packaging until just before use. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Oxytrol System out of the reach of children and away from pets.


General information:


  • If you have any questions about Oxytrol System, please talk with your doctor, pharmacist, or other health care provider.

  • Oxytrol System is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Oxytrol System. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Oxytrol resources


  • Oxytrol Side Effects (in more detail)
  • Oxytrol Use in Pregnancy & Breastfeeding
  • Oxytrol Drug Interactions
  • Oxytrol Support Group
  • 9 Reviews for Oxytrol - Add your own review/rating


Compare Oxytrol with other medications


  • Dysuria
  • Overactive Bladder
  • Urinary Incontinence

Terizidone




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J04AK03

CAS registry number (Chemical Abstracts Service)

0025683-71-0

Chemical Formula

C14-H14-N4-O4

Molecular Weight

302

Therapeutic Category

Antitubercular agent

Chemical Name

3-Isoxazolidinone, 4,4'-[1,4-phenylenebis(methylidynenitrilo)]bis-

Foreign Names

  • Terizidonum (Latin)
  • Terizidon (German)
  • Térizidone (French)
  • Terizidona (Spanish)

Generic Names

  • Terizidone (OS: DCIT)
  • R 2360 (IS)

Brand Names

  • Terivalidin
    Aventis, South Africa


  • Terizidon
    Fatol, Lithuania; Fatol, Latvia; Riemser, Germany

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Codicompren




Codicompren may be available in the countries listed below.


Ingredient matches for Codicompren



Codeine

Codeine phosphate hemihydrate (a derivative of Codeine) is reported as an ingredient of Codicompren in the following countries:


  • Germany

International Drug Name Search

Friday, 24 December 2010

Propofol Farma-Aps




Propofol Farma-Aps may be available in the countries listed below.


Ingredient matches for Propofol Farma-Aps



Propofol

Propofol is reported as an ingredient of Propofol Farma-Aps in the following countries:


  • Portugal

International Drug Name Search

Thursday, 23 December 2010

Ceva Leval




Ceva Leval may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ceva Leval



Albendazole

Albendazole is reported as an ingredient of Ceva Leval in the following countries:


  • South Africa

Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Ceva Leval in the following countries:


  • South Africa

International Drug Name Search

Wednesday, 22 December 2010

Apo-Doxycycline




Apo-Doxycycline may be available in the countries listed below.


Ingredient matches for Apo-Doxycycline



Doxycycline

Doxycycline is reported as an ingredient of Apo-Doxycycline in the following countries:


  • Guyana

International Drug Name Search

Friday, 17 December 2010

Cox




Cox may be available in the countries listed below.


Ingredient matches for Cox



Celecoxib

Celecoxib is reported as an ingredient of Cox in the following countries:


  • Argentina

International Drug Name Search

Sunday, 12 December 2010

Tilactase




Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

A09AA04

CAS registry number (Chemical Abstracts Service)

0009031-11-2

Therapeutic Categories

Enzyme

Drug for metabolic disease treatment

Chemical Name

ß-D-Galactosidase (WHO)

Foreign Names

  • Tilactasum (Latin)
  • Tilactase (German)
  • Tilactase (French)
  • Tilactasa (Spanish)

Generic Names

  • Tilactase (OS: JAN)
  • Galactosidase, ß-D- (IS)
  • Lactase (PH: USP 32)
  • ß-Galactosidase (Aspergillus) (PH: JP XV)
  • ß-Galactosidase (Penicillium) (PH: JP XV)

Brand Names

  • Carrashimease
    Tsuruhara Seiyaku, Japan


  • Dairy Ease
    Blistex, United States


  • Dairy Free
    SteriMax, Canada


  • DairyCare
    Plainview, United States


  • Deminase
    Fuso Pharmaceutical, Japan


  • Galantase
    Tanabe Mitsubishi, Japan


  • Lacdigest
    Grogg Pharma, Switzerland; Italchimici, Italy


  • Lactaid
    McNeil, United States; McNeil Consumer Healthcare, Canada


  • Lactas
    Dominguez, Argentina


  • Lactase
    Strathmann, Hungary


  • Lactosanol
    Schwarz, Poland


  • Lactosi
    Inhospi, Guatemala; Inhospi, El Salvador


  • Lactrase
    Schwarz, United States


  • Lactyme
    Wakamoto, Japan


  • Lisolac
    Pentafarma, Portugal


  • Millact
    Shionogi Seiyaku, Japan


  • N-Lactase
    Nisshin Seiyaku - Yamagata, Japan


  • Oryzatym
    Yakult, Japan


  • Silact
    Sofar, Italy


  • TilactaMed
    Strathmann, Germany


  • Tilactase Farmoz
    Farmoz, Portugal

International Drug Name Search

Glossary

ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 11 December 2010

ALK Soluprick Negativ kontrol




ALK Soluprick Negativ kontrol may be available in the countries listed below.


Ingredient matches for ALK Soluprick Negativ kontrol



Glycerol

Glycerol is reported as an ingredient of ALK Soluprick Negativ kontrol in the following countries:


  • Denmark

International Drug Name Search

Tadol




Tadol may be available in the countries listed below.


Ingredient matches for Tadol



Tramadol

Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Tadol in the following countries:


  • Denmark

  • Slovenia

International Drug Name Search

Thursday, 9 December 2010

Simet




Simet may be available in the countries listed below.


Ingredient matches for Simet



Simeticone

Simeticone is reported as an ingredient of Simet in the following countries:


  • Poland

International Drug Name Search

Sunday, 5 December 2010

Lactulosa




Lactulosa may be available in the countries listed below.


Ingredient matches for Lactulosa



Lactulose

Lactulose is reported as an ingredient of Lactulosa in the following countries:


  • Chile

  • Ecuador

International Drug Name Search

Efferalganodis




In the US, Efferalganodis is a member of the drug class miscellaneous analgesics and is used to treat Fever, Muscle Pain, Pain and Sciatica.

Ingredient matches for Efferalganodis



Paracetamol

Paracetamol is reported as an ingredient of Efferalganodis in the following countries:


  • Benin

  • Burkina Faso

  • Burundi

  • Cameroon

  • Central African Republic

  • Chad

  • Congo

  • Cote D'ivoire

  • France

  • Gabon

  • Guinea

  • Madagascar

  • Mali

  • Mauritania

  • Mauritius

  • Niger

  • Senegal

  • Togo

  • Zaire

International Drug Name Search

Saturday, 27 November 2010

Amikacin Sulfate Injection




Amikacin Sulfate Injection may be available in the countries listed below.


Ingredient matches for Amikacin Sulfate Injection



Amikacin

Amikacin sulfate (a derivative of Amikacin) is reported as an ingredient of Amikacin Sulfate Injection in the following countries:


  • Canada

International Drug Name Search

Friday, 26 November 2010

Vero-Mitomycin




Vero-Mitomycin may be available in the countries listed below.


Ingredient matches for Vero-Mitomycin



Mitomycin

Mitomycin is reported as an ingredient of Vero-Mitomycin in the following countries:


  • Russian Federation

International Drug Name Search

Wednesday, 24 November 2010

Clocortolone Pivalate




Clocortolone Pivalate may be available in the countries listed below.


Ingredient matches for Clocortolone Pivalate



Clocortolone

Clocortolone Pivalate (USAN) is known as Clocortolone in the US.

International Drug Name Search

Glossary

USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 23 November 2010

Metformine Isomed




Metformine Isomed may be available in the countries listed below.


Ingredient matches for Metformine Isomed



Metformin

Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metformine Isomed in the following countries:


  • France

International Drug Name Search

Sunday, 21 November 2010

Synulox




Synulox may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Synulox



Amoxicillin

Amoxicillin is reported as an ingredient of Synulox in the following countries:


  • Austria

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Synulox in the following countries:


  • Austria

  • Belgium

  • Finland

  • France

  • Germany

  • Italy

  • Luxembourg

  • Netherlands

  • Norway

  • Portugal

  • South Africa

  • Sweden

  • Switzerland

  • United Kingdom

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Synulox in the following countries:


  • Austria

  • Belgium

  • Finland

  • France

  • Germany

  • Italy

  • Luxembourg

  • Netherlands

  • Norway

  • Portugal

  • South Africa

  • Sweden

  • Switzerland

  • United Kingdom

International Drug Name Search

Pehatrim




Pehatrim may be available in the countries listed below.


Ingredient matches for Pehatrim



Sulfamethoxazole

Sulfamethoxazole is reported as an ingredient of Pehatrim in the following countries:


  • Indonesia

Trimethoprim

Trimethoprim is reported as an ingredient of Pehatrim in the following countries:


  • Indonesia

International Drug Name Search

Wednesday, 17 November 2010

Carboplatinum Cytosafe-Pharmacia




Carboplatinum Cytosafe-Pharmacia may be available in the countries listed below.


Ingredient matches for Carboplatinum Cytosafe-Pharmacia



Carboplatin

Carboplatin is reported as an ingredient of Carboplatinum Cytosafe-Pharmacia in the following countries:


  • Luxembourg

International Drug Name Search

Tamoxifen AL




Tamoxifen AL may be available in the countries listed below.


Ingredient matches for Tamoxifen AL



Tamoxifen

Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Tamoxifen AL in the following countries:


  • Germany

International Drug Name Search

Thursday, 11 November 2010

Penciclovir Sodium




Penciclovir Sodium may be available in the countries listed below.


Ingredient matches for Penciclovir Sodium



Penciclovir

Penciclovir Sodium (USAN) is known as Penciclovir in the US.

International Drug Name Search

Glossary

USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Monday, 8 November 2010

Lisinal




Lisinal may be available in the countries listed below.


Ingredient matches for Lisinal



Lisinopril

Lisinopril is reported as an ingredient of Lisinal in the following countries:


  • Argentina

International Drug Name Search

Thursday, 4 November 2010

Dimenhydrinate Tablets


Pronunciation: dye-men-HYE-dri-nate
Generic Name: Dimenhydrinate
Brand Name: Examples include Dramamine and Travel-Eze


Dimenhydrinate is used for:

Preventing and treating nausea, vomiting, and dizziness caused by motion sickness. It may also be used for other conditions as determined by your doctor.


Dimenhydrinate is an antihistamine and anticholinergic. It works in the brain to decrease nausea, vomiting, and dizziness.


Do NOT use Dimenhydrinate if:


  • you are allergic to any ingredient in Dimenhydrinate or other similar medicines

  • you are taking sodium oxybate (GHB)

  • you are currently taking or have taken a monoamine oxidase (MAO) inhibitor (eg, phenelzine) in the past 14 days

  • you are breast-feeding

Contact your doctor or health care provider right away if any of these apply to you.



Before using Dimenhydrinate:


Some medical conditions may interact with Dimenhydrinate. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant or planning to become pregnant

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have asthma, chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, lung disease, shortness of breath, or sleep apnea

  • if you have a blockage of the stomach, intestine, or urinary tract; difficulty urinating; diabetes; ulcers; enlargement of the prostate; glaucoma; heart disease; irregular heartbeat; high blood pressure; porphyria; or thyroid disease

Some MEDICINES MAY INTERACT with Dimenhydrinate. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Sodium oxybate (GHB) because an increase in sleep duration and a decrease in the ability to breathe are likely to occur

  • MAO inhibitors (eg, phenelzine) because serious side effects, such as high blood pressure or seizure, may occur

  • Antibiotics that may cause hearing problems (eg, gentamicin, vancomycin) because Dimenhydrinate may mask symptoms of hearing problems

This may not be a complete list of all interactions that may occur. Ask your health care provider if Dimenhydrinate may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Dimenhydrinate:


Use Dimenhydrinate as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Dimenhydrinate may be taken with or without food.

  • Use Dimenhydrinate exactly as directed on the package, unless instructed differently by your doctor. If you are taking Dimenhydrinate without a prescription, follow any warnings and precautions on the label.

  • Take the first dose at least 30 minutes before activity or travel.

  • If you miss a dose of Dimenhydrinate and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Dimenhydrinate.



Important safety information:


  • Dimenhydrinate may cause drowsiness or dizziness. Do not drive, operate machinery, or do anything else that could be dangerous until you know how you react to Dimenhydrinate. Using Dimenhydrinate alone, with certain other medicines, or with alcohol may lessen your ability to drive or to perform other potentially dangerous tasks.

  • Avoid drinking alcohol or taking other medications that cause drowsiness (eg, sedatives, tranquilizers) while taking Dimenhydrinate. Dimenhydrinate will add to the effects of alcohol and other depressants. Ask your pharmacist if you have questions about which medicines are depressants.

  • Dimenhydrinate may cause dizziness. Alcohol, hot weather, exercise, and fever can increase this effect. To prevent it, sit up or stand slowly, especially in the morning. Also, sit or lie down at the first sign of dizziness.

  • Do not exceed the recommended dose or use Dimenhydrinate more frequently or for longer than prescribed without first checking with your doctor.

  • Do not become overheated in hot weather or during exercise or other activities since heatstroke may occur.

  • Dimenhydrinate may cause increased sensitivity to the sun. Avoid exposure to the sun, sunlamps, or tanning booths until you know how you react to Dimenhydrinate. Use a sunscreen or protective clothing if you must be outside for a prolonged period.

  • Do not use Dimenhydrinate with any medicine that contains diphenhydramine. Before you begin taking any new prescription or nonprescription medicine, including one used on the skin, read the ingredients to see if it also contains diphenhydramine or another similar medicine (eg, antihistamine). If it does, or if you are uncertain if it does, contact your doctor or pharmacist.

  • Use Dimenhydrinate with caution in the ELDERLY because they may be more sensitive to its effects, especially dizziness, sedation, and lightheadedness upon standing.

  • Safe use and instructions for use in CHILDREN differs according to the brand used. Talk to your doctor or pharmacist if you have any questions about the brand you are using.

  • Use of Dimenhydrinate is not recommended in CHILDREN younger than 2 years of age without first talking with the child's doctor. Safety and effectiveness in this age group have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, discuss with your doctor the benefits and risks of using Dimenhydrinate during pregnancy. Dimenhydrinate is excreted in breast milk. Do not breast-feed while taking Dimenhydrinate.


Possible side effects of Dimenhydrinate:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dizziness; drowsiness; dry mouth, throat, and nose; thickening of mucus in nose or throat.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; convulsions; decreased alertness; difficulty urinating; excessive excitability; fast or irregular heartbeat; fever, chills, or sore throat; hallucinations; mental or mood changes; pounding in the chest; seizures; tremor; unusual bruising or bleeding; wheezing; yellowing of the eyes or skin.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Dimenhydrinate side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include coma; excitement; hallucinations; loss of consciousness; muscle twitching; seizures; severe drowsiness; tremor; weakness.


Proper storage of Dimenhydrinate:

Store Dimenhydrinate at room temperature, between 68 and 77 degrees F (20 and 25 degrees C), or according to directions on the package label. Store in the original package or container. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dimenhydrinate out of the reach of children and away from pets.


General information:


  • If you have any questions about Dimenhydrinate, please talk with your doctor, pharmacist, or other health care provider.

  • Dimenhydrinate is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Dimenhydrinate. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Dimenhydrinate resources


  • Dimenhydrinate Side Effects (in more detail)
  • Dimenhydrinate Dosage
  • Dimenhydrinate Use in Pregnancy & Breastfeeding
  • Drug Images
  • Dimenhydrinate Drug Interactions
  • Dimenhydrinate Support Group
  • 12 Reviews for Dimenhydrinate - Add your own review/rating


Compare Dimenhydrinate with other medications


  • Motion Sickness
  • Nausea/Vomiting

Monday, 1 November 2010

Olopatadine Spray


Pronunciation: OH-loe-PA-ta-deen
Generic Name: Olopatadine
Brand Name: Patanase


Olopatadine Spray is used for:

Treating allergy symptoms such as sneezing and itchy, runny nose. It may also be used for other conditions as determined by your doctor.


Olopatadine Spray is an antihistamine nasal spray. It works by blocking the action of histamine, which reduces allergy symptoms.


Do NOT use Olopatadine Spray if:


  • you are allergic to any ingredient in Olopatadine Spray

Contact your doctor or health care provider right away if any of these apply to you.



Before using Olopatadine Spray:


Some medical conditions may interact with Olopatadine Spray. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have an infection in the nose, a history of nasal injury, or any other nose problems (eg, blockage, narrowing, sores, ulcers)

Some MEDICINES MAY INTERACT with Olopatadine Spray. Because little, if any, of Olopatadine Spray is absorbed into the blood, the risk of it interacting with another medicine is low.


Ask your health care provider if Olopatadine Spray may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Olopatadine Spray:


Use Olopatadine Spray as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Before using Olopatadine Spray for the first time, you must prime the pump. To do this, point the pump away from yourself and others. Spray 5 times or until a fine mist appears.

  • Re-prime the pump if it has not been used for more than 7 days. To do this, point the pump away from yourself and others, then spray 2 times.

  • To use a nose spray, gently blow your nose. Tip your head down with your chin toward your chest and place the tip of the spray container into the nose. Be sure to aim the container tip toward the cheek side of the nose away from the center of the nose. Using a finger from your other hand, press against the opposite nostril to close it off. Breathe gently through the open nostril and squeeze the spray container. If you are using more than 1 spray, wait for 1 to 2 minutes between sprays. Do not tip your head back or blow your nose right after using Olopatadine Spray. After using the medicine, rinse the tip of the spray unit in hot water and dry with a clean tissue to prevent contamination.

  • Throw away any medicine that is left in the bottle after you have used 240 sprays (not counting the sprays used to prime the bottle for the first time). You may no longer receive the correct amount of medicine with each spray.

  • If you miss a dose of Olopatadine Spray, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Olopatadine Spray.



Important safety information:


  • Olopatadine Spray is for the nose only. Do not get it in your eyes or mouth. If you get it in these areas, rinse with cool tap water at once.

  • Olopatadine Spray may cause drowsiness. This effect may be worse if you take it with alcohol or certain medicines. Use Olopatadine Spray with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Olopatadine Spray; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Do NOT use more than the recommended dose without checking with your doctor.

  • The medicine has an antihistamine in it. Before you start any new medicine, check the label to see if it has an antihistamine (eg, diphenhydramine) in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • Olopatadine Spray should be used with extreme caution in CHILDREN younger than 6 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Olopatadine Spray while you are pregnant. It is not known if Olopatadine Spray is found in breast milk. If you are or will be breast-feeding while you use Olopatadine Spray, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Olopatadine Spray:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Bitter taste; cough; drowsiness; headache; mild nosebleed; mild sore throat.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fever; repeated or persistent nosebleeds; severe nasal irritation; sores in the nose.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.



If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include agitation; restlessness; severe drowsiness.


Proper storage of Olopatadine Spray:

Store Olopatadine Spray between 39 and 77 degrees F (4 and 25 degrees C). Store away from heat, moisture, and light. Keep Olopatadine Spray out of the reach of children and away from pets.


General information:


  • If you have any questions about Olopatadine Spray, please talk with your doctor, pharmacist, or other health care provider.

  • Olopatadine Spray is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Olopatadine Spray. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Olopatadine resources


  • Olopatadine Use in Pregnancy & Breastfeeding
  • Olopatadine Drug Interactions
  • Olopatadine Support Group
  • 7 Reviews for Olopatadine - Add your own review/rating


Compare Olopatadine with other medications


  • Hay Fever

Tuesday, 26 October 2010

Ketolgan




Ketolgan may be available in the countries listed below.


Ingredient matches for Ketolgan



Ketorolac

Ketorolac is reported as an ingredient of Ketolgan in the following countries:


  • Lithuania

International Drug Name Search

Clomifeno Ethical




Clomifeno Ethical may be available in the countries listed below.


Ingredient matches for Clomifeno Ethical



Clomifene

Clomifene citrate (a derivative of Clomifene) is reported as an ingredient of Clomifeno Ethical in the following countries:


  • Dominican Republic

International Drug Name Search

Monday, 25 October 2010

Cardilor




Cardilor may be available in the countries listed below.


Ingredient matches for Cardilor



Amiodarone

Amiodarone hydrochloride (a derivative of Amiodarone) is reported as an ingredient of Cardilor in the following countries:


  • Bahrain

  • Jordan

  • Kenya

  • Malta

  • Sudan

  • Yemen

  • Zimbabwe

International Drug Name Search

Sunday, 24 October 2010

Pharex Amoxicillin Trihydrate




Pharex Amoxicillin Trihydrate may be available in the countries listed below.


Ingredient matches for Pharex Amoxicillin Trihydrate



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Pharex Amoxicillin Trihydrate in the following countries:


  • Philippines

International Drug Name Search

Saturday, 23 October 2010

Clar




Clar may be available in the countries listed below.


Ingredient matches for Clar



Clarithromycin

Clarithromycin is reported as an ingredient of Clar in the following countries:


  • Romania

International Drug Name Search

Wednesday, 20 October 2010

Osnervan




Osnervan may be available in the countries listed below.


Ingredient matches for Osnervan



Procyclidine

Procyclidine hydrochloride (a derivative of Procyclidine) is reported as an ingredient of Osnervan in the following countries:


  • Germany

International Drug Name Search

Monday, 18 October 2010

Kdrine




Kdrine may be available in the countries listed below.


Ingredient matches for Kdrine



Procyclidine

Procyclidine hydrochloride (a derivative of Procyclidine) is reported as an ingredient of Kdrine in the following countries:


  • Bangladesh

International Drug Name Search

Tuesday, 28 September 2010

Finasterid Winthrop




Finasterid Winthrop may be available in the countries listed below.


Ingredient matches for Finasterid Winthrop



Finasteride

Finasteride is reported as an ingredient of Finasterid Winthrop in the following countries:


  • Germany

International Drug Name Search

Monday, 27 September 2010

Cefepima




Cefepima may be available in the countries listed below.


Ingredient matches for Cefepima



Cefepime

Cefepime is reported as an ingredient of Cefepima in the following countries:


  • Peru

International Drug Name Search

Thursday, 23 September 2010

Glimepiride Winthrop




Glimepiride Winthrop may be available in the countries listed below.


Ingredient matches for Glimepiride Winthrop



Glimepiride

Glimepiride is reported as an ingredient of Glimepiride Winthrop in the following countries:


  • Estonia

  • Latvia

  • Netherlands

  • Switzerland

International Drug Name Search

Tuesday, 21 September 2010

Youaneto




Youaneto may be available in the countries listed below.


Ingredient matches for Youaneto



Aldioxa

Aldioxa is reported as an ingredient of Youaneto in the following countries:


  • Japan

International Drug Name Search

Saturday, 18 September 2010

Ecosal




Ecosal may be available in the countries listed below.


Ingredient matches for Ecosal



Salbutamol

Salbutamol is reported as an ingredient of Ecosal in the following countries:


  • Latvia

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Ecosal in the following countries:


  • Belgium

  • Bulgaria

  • Croatia (Hrvatska)

  • Czech Republic

  • Estonia

  • Hungary

  • Serbia

  • Slovakia

International Drug Name Search

Duraclon


Pronunciation: KLON-i-deen
Generic Name: Clonidine
Brand Name: Duraclon

Duraclon is not recommended for treating pain during or following childbirth, or that associated with surgery because of the risk of developing very low blood pressure and an unusually slow heartbeat. However, there may be rare situations in which the potential benefits may outweigh the possible risks. Contact your doctor for more details.





Duraclon is used for:

Treating severe pain along with opioid (narcotic) pain medicines in certain cancer patients. It may also be used for other conditions as determined by your doctor.


Duraclon is an alpha-agonist analgesic. It works in the spinal cord by preventing pain signal transmission to the brain.


Do NOT use Duraclon if:


  • you are allergic to any ingredient in Duraclon

  • you have bleeding problems

  • you have an infection at the injection site

  • you are taking an anticoagulant (eg, warfarin, heparin)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Duraclon:


Some medical conditions may interact with Duraclon. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of kidney problems, blood vessel problems (eg, in the brain), heart problems, high or low blood pressure, the blood disease porphyria, or mental or mood problems (eg, depression)

  • if you have low blood volume or you have had a stroke or a recent heart attack

  • if you are scheduled for surgery

Some MEDICINES MAY INTERACT with Duraclon. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Anticoagulant therapy (eg, warfarin, heparin) because the risk of bleeding at the injection site may be increased

  • Beta-blockers (eg, propranolol), calcium channel blockers (eg, verapamil), or digoxin because the risk of slow or irregular heartbeat may be increased

  • Tricyclic antidepressants (eg, amitriptyline) because they may decrease Duraclon's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Duraclon may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Duraclon:


Use Duraclon as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Duraclon is usually given by continuous epidural infusion devices at your doctor's office, hospital, or clinic. If you will be using Duraclon at home, a health care provider will teach you how to use it. Be sure you understand how to use Duraclon. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.

  • Do not use Duraclon if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.

  • Do not suddenly stop taking Duraclon. You may have an increased risk of side effects. If you need to stop Duraclon, your doctor will gradually lower your dose. Contact your doctor right away if the medicine infusion is interrupted for any reason.

  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.

  • If you miss a dose of Duraclon, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Duraclon.



Important safety information:


  • Duraclon may cause drowsiness, dizziness, or light-headedness. These effects may be worse if you take it with alcohol or certain medicines. Use Duraclon with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Check with your doctor before you drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Duraclon; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Duraclon may cause dizziness, light-headedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Do not suddenly stop taking Duraclon. Doing so may cause withdrawal symptoms like nervousness, irritability, or shakiness. You could also get a headache and high blood pressure. The risk of these effects may be greater if you have been taking high doses of Duraclon. The risk may also be greater if you are taking a beta-blocker (eg, atenolol). Rarely, very serious effects like increased blood pressure in the brain, stroke, and death have occurred in patients who have suddenly stopped using Duraclon. Discuss any questions or concerns with your doctor.

  • Duraclon may cause low blood pressure. This effect has occurred most often within the first 4 days after starting Duraclon, although it may occur at any time while using Duraclon. The risk may be higher in women and in lower weight patients. Contact your doctor right away if you experience symptoms of low blood pressure (eg, fainting, light-headedness, severe or persistent dizziness).

  • Tell your doctor or dentist that you take Duraclon before you receive any medical or dental care, emergency care, or surgery.

  • Lab tests, including blood pressure, may be performed while you use Duraclon. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Duraclon should be used with extreme caution in CHILDREN; use is limited to children old enough to tolerate placement and management of an epidural catheter.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Duraclon while you are pregnant. Duraclon is found in breast milk. Do not breast-feed while using Duraclon.

If you stop taking Duraclon suddenly, you may have WITHDRAWAL symptoms. These may include nervousness, agitation, headache, tremor, and rapid increase in blood pressure.



Possible side effects of Duraclon:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Anxiety; confusion; constipation; dizziness; drowsiness; dry mouth; general weakness; nausea; ringing in the ears; sweating; tiredness; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain; depression; fainting; fast, slow, or irregular heartbeat; fever, chills, or persistent sore throat; hallucinations; light-headedness; painful or difficult urination; severe or persistent dizziness; shortness of breath; slow or shallow breathing.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Duraclon side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Accidental overdose of Duraclon is an increasing cause of poisoning in children 3 years old and younger. Symptoms may include decreased or absent reflexes; difficult or slow breathing; drowsiness; irritability; pinpoint pupils; seizures; severe or persistent headache; slow or irregular heartbeat; symptoms of hypothermia (eg, shivering, sluggishness, confusion, mental or mood changes, coma); symptoms of low blood pressure (eg, fainting; light-headedness; severe dizziness).


Proper storage of Duraclon:

Duraclon is usually handled and stored by a health care provider. If you are using Duraclon at home, store Duraclon as directed by your pharmacist or health care provider. Keep Duraclon out of the reach of children and away from pets.


General information:


  • If you have any questions about Duraclon, please talk with your doctor, pharmacist, or other health care provider.

  • Duraclon is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Duraclon. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Duraclon resources


  • Duraclon Side Effects (in more detail)
  • Duraclon Use in Pregnancy & Breastfeeding
  • Duraclon Drug Interactions
  • Duraclon Support Group
  • 0 Reviews for Duraclon - Add your own review/rating


  • Duraclon Advanced Consumer (Micromedex) - Includes Dosage Information

  • Duraclon Prescribing Information (FDA)

  • Catapres Consumer Overview

  • Catapres Advanced Consumer (Micromedex) - Includes Dosage Information

  • Catapres Prescribing Information (FDA)

  • Clonidine Monograph (AHFS DI)

  • Kapvay Consumer Overview

  • Kapvay Prescribing Information (FDA)

  • Nexiclon XR Prescribing Information (FDA)



Compare Duraclon with other medications


  • Pain
  • Postanesthetic Shivering

Wednesday, 15 September 2010

Zitrocin




Zitrocin may be available in the countries listed below.


Ingredient matches for Zitrocin



Azithromycin

Azithromycin is reported as an ingredient of Zitrocin in the following countries:


  • Tunisia

Azithromycin dihydrate (a derivative of Azithromycin) is reported as an ingredient of Zitrocin in the following countries:


  • Czech Republic

  • Hungary

  • Slovakia

  • Slovenia

International Drug Name Search

Voltaren Dolo Filmtabletten




Voltaren Dolo Filmtabletten may be available in the countries listed below.


Ingredient matches for Voltaren Dolo Filmtabletten



Diclofenac

Diclofenac potassium salt (a derivative of Diclofenac) is reported as an ingredient of Voltaren Dolo Filmtabletten in the following countries:


  • Austria

  • Switzerland

International Drug Name Search

Rifapentine




In the US, Rifapentine (rifapentine systemic) is a member of the drug class rifamycin derivatives and is used to treat Tuberculosis, Active.

US matches:

  • Rifapentine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J04AB05

CAS registry number (Chemical Abstracts Service)

0061379-65-5

Chemical Formula

C47-H64-N4-O12

Molecular Weight

877

Therapeutic Categories

Antibacterial

Antitubercular agent

Chemical Name

Rifamycin, 3-[[4-cyclopentyl-1-piperazinyl)imino]methyl]-

Foreign Names

  • Rifapentinum (Latin)
  • Rifapentin (German)
  • Rifapentine (French)
  • Rifapentina (Spanish)

Generic Names

  • Rifapentina (OS: DCIT)
  • Rifapentine (OS: USAN, BAN)
  • DL 473 (IS)
  • DL 473-IT (IS)
  • L 11473 (IS)
  • MDL 473 (IS)
  • R 773 (IS)

Brand Name

  • Priftin
    Sanofi-Aventis, United States

International Drug Name Search

Glossary

BANBritish Approved Name
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, 14 September 2010

Topron




Topron may be available in the countries listed below.


Ingredient matches for Topron



Nifuroxazide

Nifuroxazide is reported as an ingredient of Topron in the following countries:


  • Dominican Republic

  • El Salvador

  • Guatemala

  • Mexico

  • Nicaragua

  • Panama

International Drug Name Search

Monday, 13 September 2010

Amloratio




Amloratio may be available in the countries listed below.


Ingredient matches for Amloratio



Amlodipine

Amlodipine is reported as an ingredient of Amloratio in the following countries:


  • Poland

Amlodipine besilate (a derivative of Amlodipine) is reported as an ingredient of Amloratio in the following countries:


  • Sweden

International Drug Name Search

Saturday, 11 September 2010

Lidocaina Infosint




Lidocaina Infosint may be available in the countries listed below.


Ingredient matches for Lidocaina Infosint



Lidocaine

Lidocaine is reported as an ingredient of Lidocaina Infosint in the following countries:


  • Romania

International Drug Name Search

Friday, 10 September 2010

Lamuran




Lamuran may be available in the countries listed below.


Ingredient matches for Lamuran



Raubasine

Raubasine is reported as an ingredient of Lamuran in the following countries:


  • Italy

International Drug Name Search

Saturday, 4 September 2010

Cofamix Ampicilline




Cofamix Ampicilline may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cofamix Ampicilline



Ampicillin

Ampicillin trihydrate (a derivative of Ampicillin) is reported as an ingredient of Cofamix Ampicilline in the following countries:


  • France

International Drug Name Search

Thursday, 2 September 2010

Multifung




Multifung may be available in the countries listed below.


Ingredient matches for Multifung



Bifonazole

Bifonazole is reported as an ingredient of Multifung in the following countries:


  • Chile

International Drug Name Search

Saturday, 28 August 2010

Doburan




Doburan may be available in the countries listed below.


Ingredient matches for Doburan



Dobutamine

Dobutamine hydrochloride (a derivative of Dobutamine) is reported as an ingredient of Doburan in the following countries:


  • Venezuela

International Drug Name Search

Saturday, 21 August 2010

Stadorf




Stadorf may be available in the countries listed below.


Ingredient matches for Stadorf



Sultopride

Sultopride hydrochloride (a derivative of Sultopride) is reported as an ingredient of Stadorf in the following countries:


  • Japan

International Drug Name Search

Thursday, 12 August 2010

Bioflen




Bioflen may be available in the countries listed below.


Ingredient matches for Bioflen



Pefloxacin

Pefloxacin mesilate (a derivative of Pefloxacin) is reported as an ingredient of Bioflen in the following countries:


  • Mexico

International Drug Name Search

Tuesday, 10 August 2010

Calcio + Magnesio Cloruro Salf




Calcio + Magnesio Cloruro Salf may be available in the countries listed below.


Ingredient matches for Calcio + Magnesio Cloruro Salf



Calcium Chloride

Calcium Chloride is reported as an ingredient of Calcio + Magnesio Cloruro Salf in the following countries:


  • Italy

Magnesium Chloride

Magnesium Chloride is reported as an ingredient of Calcio + Magnesio Cloruro Salf in the following countries:


  • Italy

International Drug Name Search

Saturday, 7 August 2010

Chlorhydrate d'Oxybutynine-Genthon




Chlorhydrate d'Oxybutynine-Genthon may be available in the countries listed below.


Ingredient matches for Chlorhydrate d'Oxybutynine-Genthon



Oxybutynin

Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Chlorhydrate d'Oxybutynine-Genthon in the following countries:


  • Luxembourg

International Drug Name Search

Friday, 6 August 2010

Cofamix OBZ




Cofamix OBZ may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Cofamix OBZ



Oxibendazole

Oxibendazole is reported as an ingredient of Cofamix OBZ in the following countries:


  • France

International Drug Name Search

Purmycin




Purmycin may be available in the countries listed below.


Ingredient matches for Purmycin



Erythromycin

Erythromycin estolate (a derivative of Erythromycin) is reported as an ingredient of Purmycin in the following countries:


  • South Africa

International Drug Name Search

Wednesday, 4 August 2010

Microgynon 21




Microgynon 21 may be available in the countries listed below.


Ingredient matches for Microgynon 21



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Microgynon 21 in the following countries:


  • Turkey

Levonorgestrel

Levonorgestrel is reported as an ingredient of Microgynon 21 in the following countries:


  • Turkey

International Drug Name Search

Tuesday, 3 August 2010

Chiodenin




Chiodenin may be available in the countries listed below.


Ingredient matches for Chiodenin



Flavin Adenine Dinucleotide

Flavin Adenine Dinucleotide is reported as an ingredient of Chiodenin in the following countries:


  • Japan

International Drug Name Search

Tetrakain Chauvin




Tetrakain Chauvin may be available in the countries listed below.


Ingredient matches for Tetrakain Chauvin



Tetracaine

Tetracaine hydrochloride (a derivative of Tetracaine) is reported as an ingredient of Tetrakain Chauvin in the following countries:


  • Sweden

International Drug Name Search

Durasal Topical


Generic Name: salicylic acid (Topical route)


sal-i-SIL-ik AS-id


Commonly used brand name(s)

In the U.S.


  • Akurza

  • Aliclen

  • Avosil

  • Betasal

  • Compound W

  • Corn Removing

  • Dermarest Psoriasis

  • DHS Sal

  • Drytex

  • Duofilm

  • Duoplant

  • Durasal

  • Freezone

  • Fung-O

  • Gets-It Corn/Callus Remover

  • Gordofilm

  • Hydrisalic

  • Ionil

  • Ionil Plus

  • Keralyt

  • Keralyt Scalp

  • Lupicare

  • Mediplast

  • Mg217 Sal-Acid

  • Mosco Corn & Callus Remover

  • Neutrogena

  • Occlusal-HP

  • Off-Ezy

  • Oxy Balance

  • P & S

  • Palmer's Skin Success Acne Cleanser

  • Propa pH

  • Salac

  • Sal-Acid Plaster

  • Salactic Film

  • Salex

  • Salitop

  • Salkera

  • Sal-Plant Gel

  • Salvax

  • Seba-Clear

  • Stri-Dex

  • Thera-Sal

  • Therasoft Anti-Acne

  • Tinamed

  • Ti-Seb

  • Virasal

  • Wart-Off Maximum Strength

  • Zapzyt

In Canada


  • Acnex

  • Acnomel Acne Mask

  • Clear Away Wart Removal System

  • Compound W One-Step Wart Remover

  • Compound W Plus

  • Dr. Scholl's Clear Away One Step Plantar Wart Remover

  • Dr. Scholl's Cushlin Ultra Slim Callus Removers

  • Dr. Scholl's Cushlin Ultra Slim Corn Removers

  • Duoforte 27

  • Freezone - One Step Callus Remover Pad

  • Freezone - One Step Corn Remover Pad

Available Dosage Forms:


  • Soap

  • Lotion

  • Liquid

  • Foam

  • Ointment

  • Gel/Jelly

  • Solution

  • Cream

  • Pad

  • Paste

  • Shampoo

  • Dressing

  • Stick

Therapeutic Class: Antiacne


Pharmacologic Class: NSAID


Chemical Class: Salicylate, Non-Aspirin


Uses For Durasal


Salicylic acid is used to treat many skin disorders, such as acne, dandruff, psoriasis, seborrheic dermatitis of the skin and scalp, calluses, corns, common warts, and plantar warts, depending on the dosage form and strength of the preparation.


Some of these preparations are available only with your doctor's prescription.


Before Using Durasal


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Young children may be at increased risk of unwanted effects because of increased absorption of salicylic acid through the skin. Also, young children may be more likely to get skin irritation from salicylic acid. Salicylic acid should not be applied to large areas of the body, used for long periods of time, or used under occlusive dressing (air-tight covering, such as kitchen plastic wrap) in infants and children. Salicylic acid should not be used in children younger than 2 years of age.


Geriatric


Elderly people are more likely to have age-related blood vessel disease. This may increase the chance of problems during treatment with this medicine.


Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Abciximab

  • Argatroban

  • Bivalirudin

  • Cilostazol

  • Citalopram

  • Clovoxamine

  • Dabigatran Etexilate

  • Dipyridamole

  • Escitalopram

  • Femoxetine

  • Flesinoxan

  • Fluoxetine

  • Fluvoxamine

  • Fondaparinux

  • Heparin

  • Lepirudin

  • Nefazodone

  • Paroxetine

  • Protein C

  • Rivaroxaban

  • Sertraline

  • Sibutramine

  • Ticlopidine

  • Tirofiban

  • Vilazodone

  • Zimeldine

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acenocoumarol

  • Anisindione

  • Ardeparin

  • Azilsartan Medoxomil

  • Azosemide

  • Bemetizide

  • Bendroflumethiazide

  • Benzthiazide

  • Bumetanide

  • Buthiazide

  • Candesartan Cilexetil

  • Certoparin

  • Chlorothiazide

  • Chlorthalidone

  • Clopamide

  • Cyclopenthiazide

  • Dalteparin

  • Danaparoid

  • Dicumarol

  • Enoxaparin

  • Eprosartan

  • Ethacrynic Acid

  • Furosemide

  • Hydrochlorothiazide

  • Hydroflumethiazide

  • Indapamide

  • Irbesartan

  • Losartan

  • Methyclothiazide

  • Metolazone

  • Nadroparin

  • Olmesartan Medoxomil

  • Parnaparin

  • Phenindione

  • Phenprocoumon

  • Piretanide

  • Polythiazide

  • Probenecid

  • Reviparin

  • Tamarind

  • Tasosartan

  • Telmisartan

  • Tinzaparin

  • Torsemide

  • Trichlormethiazide

  • Valsartan

  • Warfarin

  • Xipamide

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Blood vessel disease

  • Diabetes mellitus (sugar diabetes)—Use of this medicine may cause severe redness or ulceration, especially on the hands or feet

  • Inflammation, irritation, or infection of the skin—Use of this medicine may cause severe irritation if applied to inflamed, irritated, or infected area of the skin

  • Influenza (flu) or

  • Varicella (chicken pox)—This medicine should not be used in children and teenagers with the flu or chicken pox. There is a risk of Reye's syndrome.

  • Kidney disease or

  • Liver disease—Using this medicine for a long time over large areas could result in unwanted effects

Proper Use of salicylic acid

This section provides information on the proper use of a number of products that contain salicylic acid. It may not be specific to Durasal. Please read with care.


It is very important that you use this medicine only as directed. Do not use more of it, do not use it more often, and do not use it for a longer time than recommended on the label, unless otherwise directed by your doctor. To do so may increase the chance of absorption through the skin and the chance of salicylic acid poisoning.


If your doctor has ordered an occlusive dressing (airtight covering, such as kitchen plastic wrap) to be applied over this medicine, make sure you know how to apply it. Since an occlusive dressing will increase the amount of medicine absorbed through your skin and the possibility of salicylic acid poisoning, use it only as directed. If you have any questions about this, check with your doctor.


Keep this medicine away from the eyes and other mucous membranes, such as the mouth and inside of the nose. If you should accidentally get some in your eyes or on other mucous membranes, immediately flush them with water for 15 minutes.


To use the cream, lotion, or ointment form of salicylic acid:


  • Apply enough medicine to cover the affected area, and rub in gently.

To use the gel form of salicylic acid:


  • Before using salicylic acid gel, apply wet packs to the affected areas for at least 5 minutes. If you have any questions about this, check with your health care professional.

  • Apply enough gel to cover the affected areas, and rub in gently.

To use the pad form of salicylic acid:


  • Wipe the pad over the affected areas.

  • Do not rinse off medicine after treatment.

To use the plaster form of salicylic acid for warts, corns, or calluses:


  • This medicine comes with patient instructions. Read them carefully before using.

  • Do not use this medicine on irritated skin or on any area that is infected or reddened. Also, do not use this medicine if you are a diabetic or if you have poor blood circulation.

  • Do not use this medicine on warts with hair growing from them or on warts on the face, in or on the genital (sex) organs, or inside the nose or mouth. Also do not use on moles or birthmarks. To do so may cause severe irritation.

  • Wash the area to be treated and dry thoroughly. Warts may be soaked in warm water for 5 minutes before drying.

  • Cut the plaster to fit the wart, corn, or callus and apply.

  • For corns and calluses:
    • Repeat every 48 hours as needed for up to 14 days, or as directed by your doctor, until the corn or callus is removed.

    • Corns or calluses may be soaked in warm water for 5 minutes to help in their removal.


  • For warts:
    • Depending on the product, either:
      • Apply plaster and repeat every 48 hours as needed, or
        • Apply plaster at bedtime, leave in place for at least 8 hours, remove plaster in the morning, and repeat every 24 hours as needed.



    • Repeat for up to 12 weeks as needed, or as directed by your doctor, until wart is removed.


  • If discomfort gets worse during treatment or continues after treatment, or if the wart spreads, check with your doctor.

To use the shampoo form of salicylic acid:


  • Before applying this medicine, wet the hair and scalp with lukewarm water. Apply enough medicine to work up a lather and rub well into the scalp for 2 or 3 minutes, then rinse. Apply the medicine again and rinse thoroughly.

To use the soap form of salicylic acid:


  • Work up a lather with the soap, using hot water, and scrub the entire affected area with a washcloth or facial sponge or mitt.

  • If you are to use this soap in a foot bath, work up rich suds in hot water and soak the feet for 10 to 15 minutes. Then pat dry without rinsing.

To use the topical solution form of salicylic acid for acne:


  • Wet a cotton ball or pad with the topical solution and wipe the affected areas.

  • Do not rinse off medicine after treatment.

To use the topical solution form of salicylic acid for warts, corns, or calluses:


  • This medicine comes with patient instructions. Read them carefully before using.

  • This medicine is flammable. Do not use it near heat or open flame or while smoking.

  • Do not use this medicine on irritated skin or on any area that is infected or reddened. Also, do not use this medicine if you are a diabetic or if you have poor blood circulation.

  • Do not use this medicine on warts with hair growing from them or on warts on the face, in or on the genital (sex) organs, or inside the nose or mouth. Also do not use on moles or birthmarks. To do so may cause severe irritation.

  • Avoid breathing in the vapors from the medicine.

  • Wash the area to be treated and dry thoroughly. Warts may be soaked in warm water for 5 minutes before drying.

  • Apply the medicine one drop at a time to completely cover each wart, corn, or callus. Let dry.

  • For warts—Repeat one or two times a day as needed for up to 12 weeks, or as directed by your doctor, until wart is removed.

  • For corns and calluses—Repeat one or two times a day as needed for up to 14 days, or as directed by your doctor, until the corn or callus is removed.

  • Corns and calluses may be soaked in warm water for 5 minutes to help in their removal.

  • If discomfort gets worse during treatment or continues after treatment, or if the wart spreads, check with your doctor.

Unless your hands are being treated, wash them immediately after applying this medicine to remove any medicine that may be on them.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For cream dosage form:
    • For corns and calluses:
      • Adults and children—Use the 2 to 10% cream as needed. Use the 25 to 60% cream one time every three to five days.



  • For gel dosage form:
    • For acne:
      • Adults and children—Use the 0.5 to 5% gel one time a day.


    • For psoriasis:
      • Adults and children—Use the 5% gel one time a day.


    • For common warts:
      • Adults and children—Use the 5 to 26% gel one time a day.



  • For lotion dosage form:
    • For acne:
      • Adults and children—Use the 1 to 2% lotion one to three times a day.


    • For dandruff and antiseborrhic dermatitis of the scalp:
      • Adults and children—Use the 1.8 to 2% lotion on the scalp one or two times a day.



  • For ointment dosage form:
    • For acne:
      • Adults and children—Use the 3 to 6% ointment as needed.


    • For psoriasis and seborrheic dermatitis:
      • Adults and children—Use the 3 to 10% ointment as needed.


    • For common warts:
      • Adults and children—Use the 3 to 10% ointment as needed. Use the 25 to 60% ointment one time every three to five days.



  • For pads dosage form:
    • For acne:
      • Adults and children—Use one to three times a day.



  • For plaster dosage form:
    • For corns, calluses, common warts, or plantar warts:
      • Adults and children—Use one time a day or one time every other day.



  • For shampoo dosage form:
    • For dandruff or seborrheic dermatitis of the scalp:
      • Adults and children—Use on the scalp one or two times a week.



  • For soap dosage form:
    • For acne:
      • Adults and children—Use as needed.



  • For topical solution dosage form:
    • For acne:
      • Adults and children—Use the 0.5 to 2% topical solution one to three times a day.


    • For common warts and plantar warts:
      • Adults and children—Use the 5 to 27% topical solution one or two times a day.


    • For corns and calluses:
      • Adults and children—Use the 12 to 27% topical solution one or two times a day.



Missed Dose


If you miss a dose of this medicine, apply it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Precautions While Using Durasal


When using salicylic acid, do not use any of the following preparations on the same affected area as this medicine, unless otherwise directed by your doctor:


  • Abrasive soaps or cleansers

  • Alcohol-containing preparations

  • Any other topical acne preparation or preparation containing a peeling agent (for example, benzoyl peroxide, resorcinol, sulfur, or tretinoin [vitamin A acid])

  • Cosmetics or soaps that dry the skin

  • Medicated cosmetics

  • Other topical medicine for the skin

To use any of the above preparations on the same affected area as salicylic acid may cause severe irritation of the skin.


Check with your doctor right away if you have nausea, vomiting, dizziness, loss of hearing, tinnitus, lethargy hyperpnea, diarrhea, and psychic disturbances. These could be symptoms of a serious condition called salicylate toxicity, especially in children under 12 years of age and patients with kidney or liver problems.


Durasal Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor as soon as possible if any of the following side effects occur:


Less common or rare
  • Skin irritation not present before use of this medicine (moderate or severe)

Frequency not known
  • Dryness and peeling of skin

  • flushing

  • redness of skin

  • unusually warm skin

Symptoms of salicylic acid poisoning
  • Confusion

  • diarrhea

  • dizziness

  • fast or deep breathing

  • headache (severe or continuing)

  • hearing loss

  • lightheadedness

  • nausea

  • rapid breathing

  • ringing or buzzing in ears (continuing)

  • severe drowsiness

  • stomach pain

  • vomiting

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Skin irritation not present before use of this medicine (mild)

  • stinging

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Durasal Topical resources


  • Durasal Topical Use in Pregnancy & Breastfeeding
  • Durasal Topical Drug Interactions
  • Durasal Topical Support Group
  • 0 Reviews for Durasal Topical - Add your own review/rating


Compare Durasal Topical with other medications


  • Acne
  • Dermatological Disorders
  • Warts